These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 14581960)
1. DTCA not real advertising issue. Saunders B N Z Med J; 2003 Sep; 116(1182):U611. PubMed ID: 14581960 [No Abstract] [Full Text] [Related]
2. Direct-to-consumer advertising--where does the public interest lie? Saunders B N Z Med J; 2003 Aug; 116(1180):U557; discussion U557. PubMed ID: 14581978 [No Abstract] [Full Text] [Related]
3. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit? Toop L; Richards D; Saunders B N Z Med J; 2003 Aug; 116(1180):U556; discussion U556. PubMed ID: 14581976 [No Abstract] [Full Text] [Related]
4. Direct-to-consumer advertising is more profitable if it is misleading. Mansfield PR; Mintzes B N Z Med J; 2003 Sep; 116(1182):U610. PubMed ID: 14581959 [No Abstract] [Full Text] [Related]
5. Medicine and the pharmaceutical industry. Baxter P Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771 [No Abstract] [Full Text] [Related]
6. Industry-to-physician marketing and the cost of prescription drugs. Chiong W Am J Bioeth; 2003; 3(3):W28-W29. PubMed ID: 14594480 [No Abstract] [Full Text] [Related]
7. Physicians' negative views of direct-to-consumer advertising (DTCA): the international evidence grows. Toop L; Richards D N Z Med J; 2004 Jun; 117(1195):U905. PubMed ID: 15282619 [No Abstract] [Full Text] [Related]
8. Prescription drug pricing: the consumer perspective. Searing A N C Med J; 2003; 64(6):300-2. PubMed ID: 14983625 [No Abstract] [Full Text] [Related]
9. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts. Brand R State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159 [No Abstract] [Full Text] [Related]
10. A multidimensional framework for specialty drug management. Bell GK; Baumann SA Manag Care; 2013 Mar; 22(3):30-5. PubMed ID: 23610804 [No Abstract] [Full Text] [Related]
11. Pharmaceuticals and medical devices: business practices. End-of-year issue brief. Jones TM Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554 [No Abstract] [Full Text] [Related]
15. The impact of direct-to-consumer advertised drugs on drug sales in the US and New Zealand. Norey E; Simone TM; Mousa SA Appl Health Econ Health Policy; 2008; 6(2-3):93-102. PubMed ID: 19231903 [TBL] [Abstract][Full Text] [Related]
16. 'One pill makes you larger...'. Don't be seduced by pharmaceutical companies. Mason DJ Am J Nurs; 2000 Dec; 100(12):7. PubMed ID: 11202788 [No Abstract] [Full Text] [Related]
17. Issues in bringing new drugs to the market. Ammann AJ Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329171 [No Abstract] [Full Text] [Related]
18. The promise and peril of direct-to-consumer prescription drug promotion on the Internet. Hall TS DePaul J Health Care Law; 2003; 7(1):1-41. PubMed ID: 15468476 [No Abstract] [Full Text] [Related]
19. Why physician's sample? Else they are trade promotional material! Agarwal RK J Indian Med Assoc; 2008 Aug; 106(8):543. PubMed ID: 18979615 [No Abstract] [Full Text] [Related]
20. PBMs: ripe for regulation. Johnson RS Food Drug Law J; 2002; 57(2):323-69. PubMed ID: 12437004 [No Abstract] [Full Text] [Related] [Next] [New Search]